🔗 Visit the ClinicalTrials.gov page for NCT03111732
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. | N Engl J Med | 2012 | 52.99 |
| 2 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | 11.89 |
| 3 | Second-line chemotherapy in advanced biliary cancer: a systematic review. | Ann Oncol | 2014 | 2.39 |